Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic

Research output: Contribution to journalJournal articleResearchpeer-review

  1. CT and MR neuroimaging findings in patients with Lyme neuroborreliosis: A national prospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. After stroke, apraxia of eyelid opening is associated with high mortality and right hemispheric infarction

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Expanding the cerebrovascular phenotype of the p.R258H variant in ACTA2 related hereditary thoracic aortic disease (HTAD)

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Public opinion and legislations related to brain death, circulatory death and organ donation

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Quantitative Muscle MRI and Clinical Findings in Women With Pathogenic Dystrophin Gene Variants

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Myopathy can be a key phenotype of membrin (GOSR2) deficiency

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Fatigue, physical activity and associated factors in 779 patients with myasthenia gravis

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Cardiac Involvement in Women With Pathogenic Dystrophin Gene Variants

    Research output: Contribution to journalJournal articleResearchpeer-review

  • International MG/COVID-19 Working Group
View graph of relations
Original languageEnglish
Article number116803
JournalJournal of the Neurological Sciences
Volume412
Pages (from-to)116803
ISSN0022-510X
DOIs
Publication statusPublished - 15 May 2020

    Research areas

  • Betacoronavirus, Clinical Trials as Topic, Coronavirus Infections/complications, Disease Management, Disease Susceptibility, Humans, Immunoglobulins, Intravenous/therapeutic use, Immunologic Factors/therapeutic use, Immunosuppressive Agents/therapeutic use, Immunotherapy, Lambert-Eaton Myasthenic Syndrome/complications, Myasthenia Gravis/complications, Pandemics, Plasma Exchange, Pneumonia, Viral/complications, Vaccines, COVID-19, SARS-CoV-2

ID: 61075256